PEPID Pulse: Tebipenem Pivoxil (Utebzi), First Oral Carbapenem Approved for Complicated Urinary Tract Infections & Ebola Virus Disease, From Zoonotic Exposure to Hemorrhagic Fever

Preview text: Don't miss out on what's new, stay updated once a month with the latest & greatest in…

Wednesday, Jul 8, 2026 at 6:09 AM EasternActiveCampaign

PEPIDPEPID Pulse: Tebipenem Pivoxil (Utebzi), First Oral Carbapenem Approved for Complicated Urinary Tract Infections & Ebola Virus Disease, From Zoonotic Exposure to Hemorrhagic Fever

Image not available

No image available for this email.

Subject: PEPID Pulse: Tebipenem Pivoxil (Utebzi), First Oral Carbapenem Approved for Complicated Urinary Tract Infections & Ebola Virus Disease, From Zoonotic Exposure to Hemorrhagic Fever
Preview text: Don't miss out on what's new, stay updated once a month with the latest & greatest in…
From: marketing@pepid.org
Brand: PEPID
ESP: ActiveCampaign
Sent: Wed Jul 8, 2026, 6:09 AM ET
Size: 81 KB
Images: 15
Links: 23, 5 of them buttons
Subject length: 180 characters

Against PEPID's usual

Sent in the 6 AM hour, which holds 6% of its emails; 32% arrive in the 3 AM hour. The subject is 180 characters; its average is 56.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: PEPID <[email protected]>
Subject: PEPID Pulse: Tebipenem Pivoxil (Utebzi), First Oral Carbapenem Approved for Complicated Urinary Tract Infections & Ebola Virus Disease, From Zoonotic Exposure to Hemorrhagic Fever
Date: Wed, 8 Jul 2026 10:09:30 +0000 (GMT)
Message-ID domain: service-3
Return-Path domain: em-777810.pepid.org
DKIM signature: d=pepid.org s=acdkim1; d=acems3.com s=acdkim1
List-Unsubscribe: Present, one-click
Mailer: ActiveCampaign Mailer
Feedback-ID sender: activecampaign

Servers it passed through, newest first

from s5.csa2.acemsb3.com [52.128.40.57] by our receiving server with ESMTPS
from (unnamed) by acems1.com with ESMTPS

Other sending headers (names only): X-KumoRef, X-DKIM-Options, X-Virtual-Mta, X-250ok-CID, x-schedule, X-Sending-Engine, X-Report-Abuse, X-lid, X-mid

Report this email

Sent just before and after

	Aug 12, 2026 6:01 AM	PEPID Pulse: Heat Stroke - Recognition, Rapid Cooling, and Critical Care & Enlicitide (Lipfendra) - The First Oral PCSK9 Inhibitor
	Aug 7, 2026 1:17 PM	💉 FDA Approves mFLUSIVA, First mRNA Flu Vaccine
	Jul 21, 2026 4:03 PM	⚠️ Cyclosporiasis Outbreak Update — What Providers Need to Know Now
	Jul 8, 2026 6:09 AM	PEPID Pulse: Tebipenem Pivoxil (Utebzi), First Oral Carbapenem Approved for Complicated Urinary Tract Infections & Ebola Virus Disease, From Zoonotic Exposure to Hemorrhagic Fever (this email)
	Jul 6, 2026 6:06 AM	PEPID's Sale Ends Tonight!
	Jul 5, 2026 3:06 PM	Tomorrow is the last day...
	Jul 3, 2026 3:07 AM	Before you fire up the grill...